Form 4: Bausch & Lomb Director Bernier Receives Annual Grant of Restricted Stock Units

Director Nathalie D. Bernier received an annual grant of 14,696 restricted stock units (RSUs) from Bausch & Lomb Corporation on August 2, 2024, according to a Form 4 filing with the SEC.

Summary

• On August 2, 2024, Nathalie D. Bernier, a director of Bausch & Lomb Corporation, acquired 14,696 common shares in the form of restricted stock units (RSUs).
• These RSUs were granted under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
• The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.
• Following this transaction, Bernier directly owns 49,325 common shares.
• The transaction was reported on August 6, 2024.

Sentiment

Score: 7

Explanation: The document reports a routine transaction (grant of RSUs) which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.

Future Outlook

The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Industry Context

Grants of restricted stock units to directors are a common practice in corporate governance to incentivize and align their interests with the long-term performance of the company.

Comparison to Industry Standards

• Director compensation packages, including RSU grants, vary significantly across the pharmaceutical and healthcare industries.
• Comparing the size and vesting schedule of Bernier's RSU grant to those of directors at comparable companies like Johnson & Johnson (JNJ) or Novartis (NVS) would provide a benchmark for assessing its relative value and alignment with industry standards.
• Factors such as company size, performance, and board composition influence the structure and magnitude of director compensation.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates